Dental Case Acceptance Statistics: What Is Actually Measured (2026)

There is no published national dental case acceptance rate. No peer-reviewed study, no ADA survey and no dataset with a disclosed method measures it. The "30-35%" figure quoted across the category appears to be a misreading of a 2016 trade article that said something quite different. What is measured, and measured well, is what delay does to attendance: in a study of 26,826 dental appointments, the no-show rate rose from 38.97% overall to 49.79% once the lead time passed five days.

Is there a national dental case acceptance rate?

No. We looked specifically, and here is where we looked. PubMed returns nothing usable: a search for "case acceptance" in dentistry surfaces trade-magazine opinion columns without abstracts, and "treatment plan acceptance" as a title or abstract term returns mostly radiotherapy physics. The ADA Health Policy Institute's dental practice research programme measures, in its own words, "earnings, practice billings and expenses, and busyness" (ADA HPI, Dental Practice Research). It does not measure case acceptance, and searching the Q4 2025 and Q1 2026 Economic Outlook releases for "case accept", "treatment plan" and "unschedul" returns nothing.

This matters more than it might seem. Case acceptance is the metric the entire dental consulting and software industry sells against, and there is no measured baseline for it. Every benchmark you have been shown is somebody's assertion.

One vendor is honest about this in public. A dental analytics company writes on its own benchmark page that its ranges "are compiled industry ranges rather than figures from a single dataset" and that "no government or peer-reviewed source publishes them as an authoritative series". That is the correct description of the state of the evidence.

Where did the 30-35% figure come from?

It appears to be a misread. The most likely origin is a July 2016 DentistryIQ column by Roger P. Levin, which states: "According to the 2016 Dental Economics / Levin Group Practice Survey, dentists are only persuading patients to move forward with treatment 61% of the time", and then adds that this is "30 percentage points below the target we train our consulting clients to attain" (DentistryIQ, 11 July 2016).

Read that carefully. The acceptance figure in the article is 61%. The 30 is the gap to a 90% consulting target. A vendor page later cited this exact article for the claim that acceptance rates "often hover around 30%". The cited article contains no 30% acceptance rate at all.

A second attribution circulating is that "the ADA's own recommendation is that 75-80% of presented cases should be accepted", cited to an ADA document called "Measuring Practice Success". That URL returns HTTP 404, and no such ADA recommendation could be located.

What is the one dataset that does exist?

A vendor one, published without a method. Henry Schein One's 2026 Catalyst Index states that "top performers achieve 75% case acceptance compared to 45% for the average practice", from what it describes as "analyzing performance across tens of thousands of DSOs, multi-location organizations, and private practices" (Henry Schein One, 14 May 2026).

The Henry Schein One figure is the best available and it is still not good. "Tens of thousands" is a customer roster, not a sample frame; there is no definition of what counted as a presented case; and the company sells the software that produces the number. Quote it if you must, with all of that attached. Do not quote it as an industry average.

What does delay actually do?

This is the part with real evidence behind it, and it is worth more than the invented decay curve it replaces, because you can check it and act on it.

Kim and colleagues reviewed new-patient screening appointments at a US dental teaching clinic over five years. In their words, "a total of 26,826 appointments and 24,419 unique patients were reviewed", of which "10,454 appointments were categorized as no-show appointments (38.97%)". The finding that matters here: "as the lead response time increased over 5 days, the no-show rate increased to 49.79%" (Kim et al., Journal of Dental Education, 2021).

The effect scales with the delay. In a 2025 analysis of "over 40,000 new patient clinic referrals for 2022", the overall non-attendance rate was 14.5%, and "patients waiting over 180 days were ten times more likely to DNA than those waiting under 30 days (OR 10.01, 95% CI 8.12 to 12.36)" (Rodriguez et al., Journal of Dentistry, 2025).

There is no dental equivalent of the primary-care advanced-access literature. A search for same-day dental treatment acceptance returns nothing, and neither does a search for advanced access in dentistry. If somebody quotes you a same-day-versus-delayed acceptance percentage for dentistry, it is not from a study.

Why do patients decline treatment?

The reasons are well understood; the percentages attached to them are not. This page used to publish a table giving cost as 62%, wanting to think about it as 28%, insurance uncertainty as 21% and so on. Those figures had no source, and a decline-reason distribution that precise would require a survey nobody has run.

What is measured, at population level rather than chair level, is that cost and coverage govern whether people engage with dentistry at all. The ADA Health Policy Institute reports that in 2023, "53% with private dental insurance had at least one dental visit" against "16% with no dental insurance" (ADA HPI, Coverage, Access & Outcomes). A patient who does not attend cannot accept a treatment plan, and the financial barrier is doing most of that work before your treatment coordinator ever speaks.

So the qualitative picture stands without the invented arithmetic. Patients decline because the cost is unclear or unaffordable, because they want time to decide, because they do not understand what their insurance covers, because they are frightened, and because they do not feel urgency about a problem that does not hurt yet. Which of those dominates in your practice is a question your own treatment coordinator can answer in a fortnight of asking, and the answer will be more useful than any national table.

Does follow-up improve case acceptance?

Almost certainly, and we are not going to give you a percentage for it, because none exists. What can be stated is the chain of reasoning and which links are evidenced:

The practical version does not need a number. A treatment plan handed over once at checkout, in a conversation the patient was not prepared for, competes with everything else in that patient's week. A call two days later, from someone who knows which tooth and what it costs, does not.

How do AI follow-up calls work?

They solve a scheduling problem rather than a persuasion problem. Practices know they should follow up on unscheduled treatment. What stops them is that follow-up calls are important but never urgent, so they lose every contest with the phone that is ringing now.

An AI phone agent calls the next business day, references the specific treatment plan, states the financial options the practice has authorised it to state, and offers real appointment slots. When the patient has a clinical question or a situation the practice has not scripted for, it escalates with the context of the conversation attached rather than guessing.

The mechanism is consistency, and it is worth being exact about what that claim is and is not. It is a claim that the call happens on every unscheduled plan rather than on the ones that survive a busy morning. It is not a claim about a conversion rate, because we have not measured one and no published study has either.

How should you measure your own case acceptance?

Since there is no benchmark to compare against, your own trend line is the only comparison available, and it is the more useful one anyway. The formula is straightforward - treatment accepted divided by treatment presented - but the definitions decide the number.

Fix three things before you start, and then never change them: whether you count by dollar value or by procedure count, whether preventive care is included, and what counts as "presented". Different answers produce very different rates, which is one reason the industry benchmarks that do circulate cannot be compared with each other even in principle.

Track by dollar value, excluding preventive care, monthly, split by provider and by procedure category. Then track the operational metrics that drive it: how many unscheduled plans received a follow-up call, how long after the appointment the first call happened, and what each touchpoint converted. Those are the numbers you can act on next week.

What should you actually do?